These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1346385)

  • 61. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines.
    Andersen LB; Fountain JW; Gutmann DH; Tarlé SA; Glover TW; Dracopoli NC; Housman DE; Collins FS
    Nat Genet; 1993 Feb; 3(2):118-21. PubMed ID: 8499944
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A multiplex-PCR test for EVI2A and EVI2B polymorphisms within the human NF1 gene.
    Rasmussen SA; Ho VT; Colman SD; Abernathy CR; Wallace MR
    Mamm Genome; 1996 Mar; 7(3):233-4. PubMed ID: 8833251
    [No Abstract]   [Full Text] [Related]  

  • 63. The effect of parental age on NF1 patients in Turkey.
    Sharafi P; Anlar B; Ersoy-Evans S; Varan A; Yılmaz OF; Turan M; Ayter S
    J Community Genet; 2018 Jul; 9(3):227-232. PubMed ID: 29143198
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Paternal mutation of YNH24 (D2S44), a probe frequently used in paternity testing.
    Vandenberghe A; Van Den Broeck M; Peeters I
    Am J Hum Genet; 1993 Jan; 52(1):206-7. PubMed ID: 8434588
    [No Abstract]   [Full Text] [Related]  

  • 65. Assigning a probability for paternity in apparent cases of mutation.
    Rothman ED; Neel JV; Hoppe FM
    Am J Hum Genet; 1981 Jul; 33(4):617-28. PubMed ID: 6942652
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service.
    Evans DG; Howard E; Giblin C; Clancy T; Spencer H; Huson SM; Lalloo F
    Am J Med Genet A; 2010 Feb; 152A(2):327-32. PubMed ID: 20082463
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Comprehensive Overview of NF1 Mutations in Iranian Patients.
    Savad S; Modarressi MH; Younesi S; Seifi-Alan M; Samadaian N; Masoomy M; Dianatpour M; Norouzi S; Amidi S; Boroumand A; Ashrafi MR; Ronagh A; Eslami M; Hashemnejad M; Nourian S; Mohammadi S; Taheri Amin MM; Heidari M; Seifi-Alan M; Shojaaldini Ardakani H; Aghamahdi F; Khalilian S; Ghafouri-Fard S
    Neuromolecular Med; 2024 Jul; 26(1):28. PubMed ID: 38954284
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of an
    Büki G; Bekő A; Bödör C; Urbán P; Németh K; Hadzsiev K; Fekete G; Kehrer-Sawatzki H; Bene J
    Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686382
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Robotic Adrenalectomy in a Patient With Neurofibromatosis Type 1 and Pheochromocytoma.
    Zhan-Moodie S; Revere AS; Hilton LR; Bolduc A
    Cureus; 2023 Apr; 15(4):e37097. PubMed ID: 37168184
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neuroblastic tumors and neurofibromatosis type 1: A retrospective multicenter study in Italy and systematic review of the literature.
    Puglisi F; Soma R; Podda M; Vetrella S; Rabusin M; Tropia S; Meli M; Russo G; Sorrentino S; Erminio G; Pulvirenti A; Ruggieri M; Di Cataldo A
    Front Pediatr; 2022; 10():950911. PubMed ID: 36405824
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Genotype-Phenotype Associations in Patients With Type-1, Type-2, and Atypical
    Büki G; Zsigmond A; Czakó M; Szalai R; Antal G; Farkas V; Fekete G; Nagy D; Széll M; Tihanyi M; Melegh B; Hadzsiev K; Bene J
    Front Genet; 2021; 12():673025. PubMed ID: 34168676
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
    Tamura R
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072574
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetic predisposition in pediatric oncology.
    Pruteanu DP; Olteanu DE; Cosnarovici R; Mihut E; Nagy V
    Med Pharm Rep; 2020 Oct; 93(4):323-334. PubMed ID: 33225257
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Maternal smoking during pregnancy and risk of phacomatoses: results from a Swedish register-based study.
    Tettamanti G; Mogensen H; Nordgren A; Feychting M
    Clin Epidemiol; 2019; 11():793-800. PubMed ID: 31564984
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
    Ahlawat S; Blakeley JO; Langmead S; Belzberg AJ; Fayad LM
    Skeletal Radiol; 2020 Feb; 49(2):199-219. PubMed ID: 31396668
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pathological fracture of non-ossifying fibroma associated with neurofibromatosis type 1.
    Gill JR; El Nakhal TM; Park SM; Chomicki M
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31331926
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical and molecular characteristics of thirty NF1 variants in Chinese patients with neurofibromatosis type 1.
    Wang W; Qin W; Ge H; Kong X; Xie C; Tang Y; Li M
    Mol Biol Rep; 2019 Aug; 46(4):4349-4359. PubMed ID: 31201679
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Parental age and risk of genetic syndromes predisposing to nervous system tumors: nested case-control study.
    Adel Fahmideh M; Tettamanti G; Lavebratt C; Talbäck M; Mathiesen T; Lannering B; Johnson KJ; Feychting M
    Clin Epidemiol; 2018; 10():729-738. PubMed ID: 29950902
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neurovascular manifestations of connective-tissue diseases: A review.
    Kim ST; Brinjikji W; Lanzino G; Kallmes DF
    Interv Neuroradiol; 2016 Dec; 22(6):624-637. PubMed ID: 27511817
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of parental age on the presence of de novo mutations - Lessons from neurofibromatosis type I.
    Dubov T; Toledano-Alhadef H; Bokstein F; Constantini S; Ben-Shachar S
    Mol Genet Genomic Med; 2016 Jul; 4(4):480-6. PubMed ID: 27468422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.